The largest database of trusted experimental protocols

Flp in cho cells

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Flp-In CHO cells are a Chinese Hamster Ovary (CHO) cell line that has been engineered to enable rapid and efficient integration of target genes into a known genomic location. The cells contain a single integrated Flp Recombination Target (FRT) site, allowing for site-specific integration of plasmids encoding the gene of interest using the Flp recombinase enzyme.

Automatically generated - may contain errors

36 protocols using flp in cho cells

1

Plasmid Integration in CHO Flp-In™ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasmids integrated into CHO Flp-In™ cells (Invitrogen, R758-07) were constructed using restriction cloning on commercial and custom vectors and constructs. The mNF and mPF plasmids integrated into the genomic FRT site with the aid of Flp-recombinase expressed from the pOG44 vector (Invitrogen, V600520). The addition of T2A::PuroR to both plasmids resulted in mNF-PuroR and mPF-PuroR constructs. The molecular cloning extensively used overlap PCR extension to fuse DNA pieces together. For a detailed description of plasmid construction, see Supplementary Methods and Supplementary Table 3 for cloning primers.
+ Open protocol
+ Expand
2

Maintenance of Diverse Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK293T cells were obtained from the American Type Culture Collection (ATCC) and maintained in Dulbecco’s modified Eagle Medium (DMEM, GIBCO) with 10% fetal bovine serum (FBS, Sigma Aldrich), 1x Penicillin/Streptomycin (GIBCO), 1 mM Sodium Pyruvate (GIBCO), 2 mM L-Glutamine (Thermo Fisher Scientific) at 37°C/5% CO2. The HeLa-derived TZM-bl reporter cell line was sourced from the NIH AIDS Reagent Program and maintained in DMEM containing 10% fetal bovine serum, 1 mM Sodium Pyruvate, 2 mM L-Glutamine (Thermo Fisher Scientific), 50 μg/ml Gentamicin (Sigma-Aldrich), and 25 mM HEPES (Biochrom) at 37°C/5% CO2. HEK293EBNA1-6E (293-6E) cells were obtained from the National Research Council Canada (NRC) and maintained in Freestyle 293 Expression Medium (Thermo Fisher Scientific) containing 0.2% Penicillin/Streptomycin at 37°C /5% CO2 with shaking at 90-120 rpm. The sex of these cell lines is unknown. CHO Flp-In™ cells (Invitrogen) were a kind gift from the lab of John Moore (Cornell University) and maintained in Ham’s F-12 Medium supplemented with 10% heat-inactivated FBS (Sigma-Aldrich), 200 U/ml Penicillin/Streptomycin, 2 mM L-Glutamine, 20 mM HEPES, 0.1 mM non-essential amino acids, 1 mM Sodium Pyruvate (GIBCO), and further supplemented with 100 μg/ml Zeocin (Invitrogen).
+ Open protocol
+ Expand
3

Characterization of Muscarinic Receptor Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO FlpIn cells were purchased from Invitrogen. DMEM and FBS were purchased from ThermoTrace. Hygromycin B was purchased from Roche Applied Science. PBS and versene were made in-house. Primers used for the generation of mutant receptors were purchased from Bioneer Pacific. The AlphaScreen Surefire pERK1/pERK2 reagents were kindly provided by TGR Biosciences. AlphaScreen streptavidin donor beads, anti-IgG (protein A) acceptor beads and [3H]NMS (specific activity 80 Ci mmol–1) were purchased from PerkinElmer Life and Analytical Sciences. Xanomeline and analogs were obtained from Karuna Therapeutics. Pilocarpine hydrochloride was purchased from ICN Biomedicals. All other chemicals, including acetylcholine, were from Sigma-Aldrich.
+ Open protocol
+ Expand
4

Cloning Siglec-15 Extracellular Chimera

Check if the same lab product or an alternative is used in the 5 most similar protocols
Siglec-15 contains a lysine residue in its transmembrane region that pairs with Dap-12. Since Dap-12 is not expressed in standard cell lines (e.g. CHO), we took another approach to expressing the extracellular portion of human Siglec-15 as a transmembrane portion of Siglec-15 by cloning a chimeric protein consisting of amino acids 1−260 of human Siglec-15 with the transmembrane and cytoplasmic tail of human CD22 fused to a C-terminal eGFP. This chimeric protein was cloned into pcDNA5/FRT/TOP/V5/His (Invitrogen) using the NheI and AgeI restriction enzymes. CHO Flp-in cells (Invitrogen) cells stably transfected with this vector according to the manufacturer’s protocol. After selection of cells with Hygromycin-B for 2 weeks, all cells were found to be expressing high levels of GFP by flow cytometry.
+ Open protocol
+ Expand
5

Culturing and Differentiating CHO and 3T3-L1 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Culture media for Chinese hamster ovary (CHO) Flp-In cells (Invitrogen, Carlsbad, CA, USA) and 3T3-L1 pre-adipocytes (Zenbio, Raleigh, NC, USA) are shown in electronic supplementary (ESM) Table 1. Cell lines were all mycoplasma negative by PCR. 3T3-L1 pre-adipocytes were grown to confluence and differentiation was induced by differentiation medium 1 for 72 h then differentiation medium 2 for a further 72 h. Adipocytes were maintained in adipocyte medium containing 1 μmol/l insulin ±1 μg/ml doxycycline (DOX). Experiments were undertaken at day 14 or 16 of differentiation.
+ Open protocol
+ Expand
6

Establish Dual RMCE CHO Cell Line

Check if the same lab product or an alternative is used in the 5 most similar protocols
Derivatives of Chinese Hamster ovary cells, CHO Flp-In cells (Invitrogen), were used as model mammalian cells. CHO Flp-In cells were propagated in F-12K medium supplemented with zeocin (100 mg/l). After the integration and the dual RMCE platform reporter vectors were delivered into genome of CHO Flp-In, the resultant cell lines were propagated in F-12K medium supplemented with hygromycin (550 mg/l).
+ Open protocol
+ Expand
7

Purification and Expression of ADAMTS13 Variants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant wild type human ADAMTS13 (WT rADAMTS13) was produced and purified as described [12 (link)]. MDTCS variants (Fig. 1B) were generated and expressed as described [26 (link)]. The T2-CUB2 deletion (Fig. 1C) and truncation (Fig. 1D) variants were constructed starting from the tetracycline-inducible pcDNA™4T/O vector (Invitrogen, Carlsbad, CA, USA) containing cDNA encoding WT ADAMTS13 with a C-terminal His- and V5-tag [28 (link)]. Deletion variants were prepared using inverse polymerase chain reaction (PCR). Sequences were verified (GATC Biotech AG, Konstanz, Germany) and T2-CUB2 deletion and truncation variants were expressed using the inducible T-REx system (Invitrogen), with exception of T2–T8 and T2-CUB2 that were expressed in CHO Flp-In cells (Invitrogen). Conditioned medium containing ADAMTS13 variants (except T2-CUB2 and T2–T8) was purified as described [12 (link)]. T2-CUB2 and T2–T8 were purified using a Ni2+-Sepharose Fast Flow column (GE Healthcare, Waukesha, WI, USA).
+ Open protocol
+ Expand
8

Radiolabeled Transport Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Radiolabeled [6,7-3 H(N)]-estradiol 17b-D-glucuronide, [6,7-3 H(N)]estrone sulfate, [ 3 H(G)]-taurocholic acid, and scintillation cocktail Ultima Gold were obtained from PerkinElmer (Schwerzenbach, Switzerland). [6,7-3 H(N)]-estradiol 17b-D-glucuronide and taurocholic acid sodium salt were from Sigma-Aldrich (St. Louis, MO). Cell Culture Material: CHO-Flp-In cells and LipofectAMINE 2000 were from Invitrogen (Carlsbad, CA). The baculovirus-expressing MRP2 (de Waart et al., 2010) was the generous gift of Drs. Paulusma and Oude Elferinik, Academic Medical Center, Amsterdam (The Netherlands).
+ Open protocol
+ Expand
9

Stable Expression of Cricetus cricetus MT1

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO-Flp-In cells (Thermo Fisher Scientific) were cultivated in the presence of zeocin (0.1 mg/mL). The cells were co-transfected with Cricetus cricetus (MG598322) MT1/pcDNA5-FRT (Cricetus cricetus MT1) and the Flp recombinase expression pOG44 plasmid using PEIpro (Invitrogen, Carlsbad, CA, USA). The CHO cells stably expressing Cricetus cricetus MT1 were selected using hygromycin (0.6 mg/mL). CHO-Flp-In-Cricetus cricetus MT1 cells were grown in HAM F12 with 2 mM glutamine and supplemented with 10% fetal calf serum. Cells were selected using antibiotic pressure (hygromycin) for 72 h. The resistant cells were pooled and the presence of the transgene confirmed by RT-PCR (not shown) using 500,000 cells. Then, up to 2 × 109 cells were grown and used to prepare the cell membranes used below.
+ Open protocol
+ Expand
10

Stable Transfection of Platypus and Clawed Frog Mel1c

Check if the same lab product or an alternative is used in the 5 most similar protocols
CHO-Flp-In cells (Thermo Fisher Scientific, Waltham, USA) were cultivated in the presence of zeocin (0.1 mg/ml). The cells were cotransfected with either platypus (cloned sequence that will be submitted to GenBank) Mel1c/pcDNA5-FRT (platypus Mel1c) or X. laevis (NM 001087919.1) Mel1c/pcDNA5-FRT (clawed frog Mel1c) and Flp recombinase expression pOG44 plasmid using PEIpro (Invitrogen, Carlsbad, CA). CHO cells stably expressing platypus Mel1c or clawed frog Mel1c were selected using hygromycin (0.6 mg/ml). CHO-Flp-In-platypus Mel1c cells were grown in HAM F12 with 2 mM glutamine and supplemented with 10% fetal calf serum. Cells were selected using antibiotic pressure (hygromycin) for 72 h. The resistant cells were pooled and the presence of the transgene confirmed by RT-PCR (not shown) using 500,000 cells. After confirmation of the presence of the transgene, the cells were amplified up to 2 x 109 cells. This material was used to prepare the cell membranes used in further pharmacological experiments.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!